Nova Leap Health Corp. (NLH) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 16.76% of over the last 5 years

Negative results in Jun 25

With ROE of 2.12%, it has a fair valuation with a 0.96 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 24 Million (Micro Cap)

P/E

24.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.07

Return on Equity

2.12%

Price to Book

0.93

Revenue and Profits:

Net Sales:

11 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

8.33%

6 Months

16.07%

1 Year

32.65%

2 Years

38.3%

3 Years

25.0%

4 Years

-43.97%

5 Years

-35.0%

Nova Leap Health Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Nova Leap Health Corp. Faces Valuation Shift Amid Declining Profit Metrics

Nova Leap Health Corp. has experienced a valuation adjustment, moving from a fair assessment to a classification of very expensive. Key financial metrics include a P/E ratio of 25 and a price-to-book value of 0.99. The company reported a significant decline in profit before tax and a mixed technical outlook.

Nova Leap Health Corp. Faces Valuation Shift Amid Mixed Financial Indicators

Nova Leap Health Corp. has experienced a recent evaluation adjustment, indicating a significant change in its valuation metrics. The company's financial landscape is characterized by a high P/E ratio and notable technical indicators suggesting a shift in stock trend. However, challenges such as declining profits and high debt remain.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

10.40%

EBIT Growth (5y)

16.76%

EBIT to Interest (avg)

-0.31

Debt to EBITDA (avg)

0.94

Net Debt to Equity (avg)

0.08

Sales to Capital Employed (avg)

1.34

Tax Ratio

29.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.68%

ROE (avg)

2.19%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.96

EV to EBIT

22.05

EV to EBITDA

12.09

EV to Capital Employed

0.96

EV to Sales

0.67

PEG Ratio

Dividend Yield

ROCE (Latest)

4.36%

ROE (Latest)

2.12%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Sideways

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 8.82% vs 10.87% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -600.00% vs -108.33% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.10",
          "val2": "10.20",
          "chgp": "8.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.80",
          "val2": "0.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.70",
          "val2": "-0.10",
          "chgp": "-600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "43.70%",
          "val2": "10.60%",
          "chgp": "3.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs -3.81% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 235.71% vs -27.27% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.30",
          "val2": "35.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.00",
          "val2": "1.80",
          "chgp": "11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-1.70",
          "chgp": "82.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.90",
          "val2": "-1.40",
          "chgp": "235.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.50%",
          "val2": "17.60%",
          "chgp": "1.59%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

11.10

10.20

8.82%

Operating Profit (PBDIT) excl Other Income

0.80

0.40

100.00%

Interest

0.10

Exceptional Items

-0.00

-0.10

100.00%

Consolidate Net Profit

-0.70

-0.10

-600.00%

Operating Profit Margin (Excl OI)

43.70%

10.60%

3.31%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 8.82% vs 10.87% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -600.00% vs -108.33% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

35.30

Operating Profit (PBDIT) excl Other Income

2.00

1.80

11.11%

Interest

0.10

0.20

-50.00%

Exceptional Items

-0.30

-1.70

82.35%

Consolidate Net Profit

1.90

-1.40

235.71%

Operating Profit Margin (Excl OI)

33.50%

17.60%

1.59%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs -3.81% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 235.71% vs -27.27% in Dec 2023

All Annual Results

Company CV

About Nova Leap Health Corp.

Nova Leap Health Corp.

Pharmaceuticals & Biotechnology

Nova Leap Health Corp is a Canada-based home health care services company. The Company provides personal home care and support services. It operates in four states: Vermont, New Hampshire, Massachusetts, and Rhode Island as well as Nova Scotia, Canada. It provides clients with on-going assistance with activities of daily living (ADL), which includes bathing, dressing, grooming, meal preparation, housekeeping, errands, transportation and medication reminders. Its care centers include Armistead Home Care, All About Home Care, Family Tree Home Care, Home Health Solutions, Always Home and Comprehensive Home Care.

Company Coordinates

Company Details

5003-7071 Bayers Rd , HALIFAX NS : B3L 2C2

Tel: 1 902 4019480

https://novaleaphealth.com/

Registrar Details

Nova Leap Health Corp.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 16.76% of over the last 5 years

Negative results in Jun 25

With ROE of 2.12%, it has a fair valuation with a 0.96 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Nova Leap Health Corp. Faces Valuation Shift Amid Declining Profit Metrics

Nova Leap Health Corp. Faces Valuation Shift Amid Mixed Financial Indicators

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Nova Leap Health Corp.

Company Coordinates